Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

BIOLOGICAL(1)
1 unique interventions1 categories

Analytics

Trial Phases

Phase 31

Trial Status

Other1

Role Distribution

Other Roles1

Activity Timeline

Clinical Trials (1)

NCT04042025Phase 3Active Not Recruiting
Long-term Follow-up Study of Patients Receiving Onasemnogene Abeparvovec-xioi
SMASpinal Muscular Atrophy Type ISpinal Muscular Atrophy Type II+1 more
StudychairStart date: 2020-02-10

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Leonard FEASSON, MD PhD

Centre Hospitalier Universitaire de Saint Etienne

Related
3 trials

Shared therapeutic areas:

Spinal Muscular Atrophy Type IJuvenile Spinal Muscular AtrophyMuscular Atrophy, Spinal
Similarity Score18%

René Gonin, PhD

Mathematical Statistician, Westat

Related
2 trials

Shared therapeutic areas:

Spinal Muscular Atrophy Type IMuscular Atrophy, Spinal, Type IIJuvenile Spinal Muscular Atrophy
Similarity Score18%

Sandra P Reyna, M.D.

Families of Spinal Muscular Atrophy

Related
2 trials

Shared therapeutic areas:

Muscular Atrophy, SpinalSpinal Muscular Atrophy Type I
Similarity Score12%

Richard Finkel, MD

St. Jude Children's Research Hospital

Related
2 trials

Shared therapeutic areas:

Muscular Atrophy, Spinal
Similarity Score6%

Miguel Angel Fernández García Miguel Angel Fernández García

Hospital Universitario La Paz

Related
1 trials

Shared therapeutic areas:

Muscular Atrophy, Spinal
Similarity Score6%

Walter Truong, MD

Gillette Children's Specialty Healthcare

Related
3 trials

Shared therapeutic areas:

Muscular Atrophy, Spinal
Similarity Score6%

Feyza Sever

Ankara City Hospital Bilkent

Related
5 trials

Shared therapeutic areas:

Muscular Atrophy, Spinal
Similarity Score6%

Sahar MA Hassanein, MD, PhD

Pediatric Department, Children's Hospital, Faculty of Medicine, Ain Shams University

Related
2 trials

Shared therapeutic areas:

Muscular Atrophy, Spinal
Similarity Score6%

Woo Hyung Lee, MD, PhD

Seoul National University Hospital

Related
2 trials

Shared therapeutic areas:

Muscular Atrophy, Spinal
Similarity Score6%

Mónica Povedano Panadés

Hospital Universitari de Bellvitge

Related
1 trials

Shared therapeutic areas:

Muscular Atrophy, Spinal
Similarity Score6%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT04042025Phase 3StudyChair

Long-term Follow-up Study of Patients Receiving Onasemnogene Abeparvovec-xioi

SMASpinal Muscular Atrophy Type ISpinal Muscular Atrophy Type II+1 more
Active Not Recruiting

All 1 trials loaded